AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2017
Dec 5, 2017
33298_dirs_2017-12-05_7b110088-1e0f-4431-8809-fd06779c83f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-12-04
Reporting Person: Schreiber Justin (Director, President, Immudyne PR, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-04 | Common Stock, par value $0.01 | P | 24867 | $0.39 | Acquired | 1993560 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.01 | 1375000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant | $0.4 | 2019-11-03 | Common Stock, par value $0.01 (67861) | 67861 | Indirect |
| Warrant | $0.4 | 2019-01-01 | Common Stock, par value $0.01 (591745) | 591745 | Indirect |
| Warrant | $0.4 | 2018-11-01 | Common Stock, par value $0.01 (217391) | 217391 | Indirect |
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17